Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 6 November 2009:
Vol. 326. no. 5954, pp. 780 - 781
DOI: 10.1126/science.326_780a
Prev | Table of Contents | Next

News of the Week

Stem Cells:

CIRM Awards Seek to Move Cell Therapies to the Clinic

Jocelyn Kaiser

Five years after it launched, the California Institute for Regenerative Medicine (CIRM) last week awarded its first disease-oriented grants—$230 million to 14 teams—intended to speed stem cell therapies to patients. In seeming contrast to its original mission, only about one-third of the 4-year grants involve research using embryonic stem (ES) cells. The state created CIRM largely to fund ES cell research, which was lagging because of Bush-era restrictions on the controversial technology.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)